Autolus seeks partner for clinical trials of pan-COVID-19 product
Autolus Therapeutics is seeking a partner for clinical development of an ACE2 fusion soluble receptor decoy designed to work against SARS-CoV-2 and its variants.
Archives for March 17, 2021